Future Founders In Life Sciences

Trevor Martin, PhD, founder and CEO Mammoth Biosciences

Online at April 12, 11 AM – 12 PM

Register Here and We’ll Send You the Zoom Link.

The Future Founders in Life Sciences Series is a free lecture series for those in life sciences, interested in starting their own company – our goal is to inspire you to just do it!

Each talk features an entrepreneur and their startup story, as well as some guidance and resources for those interested in learning more about the startup process. Come and meet people others interested in life science startups, as well as members of the MBC BioLabs and Y Combinator teams who have funded over 300 bio startups between them.



About Our Presenter

Dr. Trevor Martin founded Mammoth Biosciences with the mission to enable the next generation of CRISPR-based synthetic biology products across therapeutics and diagnostics, including a novel class of affordable, effective, and rapid CRISPR-enabled molecular diagnostics that allow individuals worldwide to better understand their health and a novel family of CRISPR Cas14 proteins that can enable in-vivo editing.

Trevor earned his BA from Princeton University and his PhD in Biology from Stanford. His work has been featured in outlets including FiveThirtyEight and The Atlantic. He is the featured healthcare honoree on the Forbes 30 Under 30 list, is on Fortune’s 40 Under 40 list, and is a Malaria No More “10 to END” innovator.

While still a graduate student at Stanford, Trevor launched Mammoth Biosciences, recruited Nobel Laureate Jennifer Doudna, secured a license from Berkeley, and signed a lease with MBC BioLabs – not a bad start for a first-time 28 year-old entrepreneur.  Since then Mammoth has raised $68mm to develop its CRISPR diagnostics platform, formed partnerships with GSK for COVID testing, as well as partnerships Millipore Sigma, and Agilent.  Now he’s a Forbes 40-Under-40 and Executive of the Year with the San Francisco Business Times.

Register for this Event: April 21, 2021, 11am-12pm PST – Online Event



About MBC BioLabs

Slide Schedule a Tour to Learn
How MBC BioLabs Can Help
Your Company Succeed.
Learn More About MBC BioLabs

Rent a Bench. Change the World.

We’ve Helped 200 Companies Raise $4.75B In Funding.

Talk about enabling awesome.

MBC BioLabs has helped 200 companies raise an average of $24.2M, for a total of $4.75B raised! When we say we enable awesome, we mean it. MBC BioLabs gives life science innovators and entrepreneurs the facilities and equipment they need to be running experiments from day 1. Seriously. We even have a tradition of doing a champagne toast for every company that runs an experiment on its first day.

MBC BioLabs frees startups from the Catch 22 of needing funding to get data, and needing data to get funding by providing the space, the equipment, and the community. Click below to tour one of our labs!

About Y Combinator

Y Combinator provides seed funding for startups. Seed funding is the earliest stage of venture funding. It pays your expenses while you’re getting started.

Some companies may need no more than seed funding. Others will go through several rounds. There is no right answer; how much funding you need depends on the kind of company you start.

At Y Combinator, our goal is to get you through the first phase. This usually means: get you to the point where you’ve built something impressive enough to raise money on a larger scale. Then we can introduce you to later stage investors—or occasionally even acquirers.

Learn More About Y Combinator